循环细胞外囊泡作为胶质母细胞瘤患者诊断、预后和监测的生物标志物
研究探讨血浆循环细胞外囊泡(EV)在胶质母细胞瘤诊断、预后和治疗反应中的价值。胶质母细胞瘤患者循环EV较健康供者增加5.5倍(P < .0001),高EV水平与更短总生存和无进展生存相关,且为总生存的独立预后参数。术后EV迅速降至正常,下降幅度与肿瘤切除程度相关,肿瘤复发时EV再次升高,部分患者早于MRI可检测的复发。
要点
- 胶质母细胞瘤患者循环EV较健康供者增加5.5倍(P < .0001)。
- 高EV水平患者总生存和无进展生存显著更短,EV浓度为总生存独立预后参数。
- EV水平与瘤周FLAIR高信号范围相关,与强化肿瘤大小无关;术后下降幅度与切除程度相关,复发时再升高。
核心结论
- 研究提示血脑屏障渗漏可能是胶质母细胞瘤患者循环EV浓度升高的主要原因。
- EV升高反映肿瘤存在,其定量可能有助于评估疾病活动性。
研究设计与样本
- 收集胶质母细胞瘤患者手术前后多个时间点的血浆样本。
- 采用纳米颗粒追踪分析和成像流式细胞术测量EV浓度。
- 通过3D重建量化肿瘤负荷和水肿,并在胶质母细胞瘤小鼠中进一步监测EV和肿瘤。
主要发现
- 胶质母细胞瘤患者循环EV较健康供者增加5.5倍(P < .0001)。
- EV水平较高的患者总生存和无进展生存显著短于EV水平较低的患者。
- 血浆EV浓度是总生存的独立预后参数。
- EV水平与瘤周液体衰减反转恢复(FLAIR)高信号范围相关,但与对比增强肿瘤大小无关,小鼠中获类似结果。
- 术后EV浓度迅速降至正常水平,下降幅度与肿瘤切除程度相关;疾病稳定期EV保持低水平,肿瘤复发时再次升高,部分患者EV回升早于MRI可检测的肿瘤复发。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Extracellular vesicles (EVs) obtained by noninvasive liquid biopsy from patient blood can serve as biomarkers. Here, we investigated the potential of circulating plasma EVs to serve as an indicator in the diagnosis, prognosis, and treatment response of glioblastoma patients. METHODS: Plasma samples were collected from glioblastoma patients at multiple timepoints before and after surgery. EV concentrations were measured by nanoparticle tracking analysis and imaging flow cytometry. Tumor burden and edema were quantified by 3D reconstruction. EVs and tumors were further monitored in glioma-bearing mice. RESULTS: Glioblastoma patients displayed a 5.5-fold increase in circulating EVs compared to healthy donors (P < .0001). Patients with higher EV levels had significantly shorter overall survival and progression-free survival than patients with lower levels, and the plasma EV concentration was an independent prognostic parameter for overall survival. EV levels correlated with the extent of peritumoral fluid-attenuated inversion recovery hyperintensity but not with the size of the contrast-enhancing tumor, and similar findings were obtained in mice. Postoperatively, EV concentrations decreased rapidly back to normal levels, and the magnitude of the decline was associated with the extent of tumor resection. EV levels remained low during stable disease, but increased again upon tumor recurrence. In some patients, EV resurgence preceded the magnetic resonance imaging detectability of tumor relapse. CONCLUSIONS: Our findings suggest that leakiness of the blood-brain barrier may primarily be responsible for the high circulating EV concentrations in glioblastoma patients. Elevated EVs reflect tumor presence, and their quantification may thus be valuable in assessing disease activity.
引用
- Ricklefs FL, Wollmann K, Salviano-Silva A, et al. Circulating extracellular vesicles as biomarker for diagnosis, prognosis, and monitoring in glioblastoma patients. Neuro Oncol. 2024. PMID: 38567448. doi:10.1093/neuonc/noae068
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。